Earnings call transcript Q1 2023

Due to licensing restrictions, you must log in to view earnings call transcripts.

Operator

Greetings, and welcome to the scPharmaceuticals First Quarter 2023 Earnings Conference Call. At this time, all participants are in listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.

It is now my pleasure to introduce your host, PJ Kelleher from LifeSci Advisors. you. Thank sir. ahead, go Please

PJ Kelleher

you, operator. Thank

other call Before not results business meaning like FUROSCIX. statements of and management, are limited call, would expectations the financial federal including, statements to make turning on statements the but and the conference All to the future to statements. following I forward-looking regarding and the facts, expected laws over management’s remarks within historical for than securities plans this forward-looking concerning scPharmaceuticals

expect, guidance, forward-looking and typically not other scPharmaceuticals affect confidence, important estimate, forward-looking and believe, to similar expressions condition to future financial project may business, are anticipate, used other are other subject factors to certain words The that performance results. intend, and guarantees operating and of statements statements. risks may target, involve and are and such identify These uncertainties

limited other outcomes are in quarterly risk These may attention and XX-Q scPharmaceuticals not these Actual by to expressed is the which by directed. differ Report your results SEC and contained forward-looking reports on or Annual include, to, what Form XX-K, is the company from reports other implied Form qualifications statements. materially with and the but filed on factors

these your in statements call, this update forward-looking as Any made except statements based law. including questions responses as by on today, scPharmaceuticals forward-looking conference or expressly to intent obligation to and are required of expectations current disclaims any

call pleasure the of Tucker, to over my John? Executive now turn scPharmaceuticals. Mr. is to Officer It Chief John

John Tucker

and provide stages FUROSCIX our financials. to for update turning our everyone of update more this President pleased This listening I afternoon’s Officer on operational to call Thank before for to launch, the webcast. you, afternoon, Vice of of over PJ, early Steve Rachael thanks detailed review and am Financial Chief the call Senior Parsons, Nokes, a to Commercial and the an then our

open call for questions. up We will your the then

pleased Notably, our the with XX. have commercial FUROSCIX with completed date launch XXX and suggests we on in-services is to April of in important on early our an and feedback XX through FUROSCIX providers since have February are that market. to indicator March in-services and XX, received continues months as completed X.X the execute Just XXX team progress well leading total being healthcare

These up initial on can in-service be treating educated entire last trained to physicians two to want contacts the as FUROSCIX. hours use office often of and the

as prescriptions growing As and detail working intended Steve prescribers efforts are will these both written momentarily, total early unique are as nicely.

pre-hospital homes. of will own systemic receive quickly to heart comfort exposure furosemide This supports failure the that very the part treatment in their on based the it equivalent IV core become patients paradigm, post-discharge, belief our of as time FUROSCIX a first in strong allows either admission for diuresis similar or

their heart at patients to hospital beneficial treated avoiding D be this readmissions, is worsening who would reimbursement failure pressure only than Not much and can admissions significant as hospitals savings in setting, to as Part face who commercial, home a accrue hospital for well Medicare and payers Medicaid and cost rather by patients. but significant

The patients indicated As indicated III Class in On-Body II to heart of the reminder, dose deliver an patients in FUROSCIX a milligram adult chronic or due will acute treatment only failure. New with Class and pulmonary Heart FUROSCIX emergency Infusor for is of congestion is FUROSCIX. XX Association use York fluid with not in situations overload for edema.

FUROSCIX were as one financial failure on to event patients two we at clearly FREEDOM-HF hospital. admitted studies a Last who of opposed presented the demonstrate home select focused heart room being FUROSCIX, the study that with treated perspective with to the benefits quarter conducted we and detailed that emergency to potential worsening

were with average of statistical lower FUROSCIX the matched rate with of was of result high versus comparators, very p X.XXXX. costs and significance $XX,XXX patients treated a achieved result that by this a study heart was an related with that The value had historically than failure less

While been at unchanged. the conclusion of pricing time not this established the of study, the cost had the FUROSCIX analysis since remains excludes

randomized study randomized the second augmented presenting as that a usual. a at study a diuresis. And compared heart chronic XX clinic a failure Among approach failure to hospitalization congestion to heart a the heart subjects reduction XX% Phase the requiring worsening had treatment-as-usual risk X with failure AT pilot HOME-HF in relative patients key FUROSCIX to findings, to of FUROSCIX patients day in treatment with

FUROSCIX work a to of staff. and compelling pharmacy the further payer physicians educate picture committees outcome with engage commercial of efforts both therapeutic dynamics. team critical provide validation They the and our provide and regarding as treating also The reimbursement support benefits of we studies of they as their

patients coverage favorable involves that of to at we Medicaid patients. FUROSCIX, discussions but and working initial only in placed D tier affordable commercial, topic not the it the On formulary most to to payers available have payers, broadly continuing productive of have a This Part continue terms Medicare be on effort to FUROSCIX possible. securing with the to most make would also a

national all in we continued indicated of are placed tier our we can would top all to under a recently commercial this formulary X. that believe XX% that approximately failure preferred FUROSCIX heart its by XX% June that of effective patients five a plan fixed access co-pays plans of FUROSCIX previously or less, increase over status we progress, $XXX We health can more. or and time notified Reflecting across

plans its Medicare its this regard favorable With as discussions and positive formulary Part beneficiaries. placement we payer a reimbursement securing development regarding goal for this similarly significant with of D the with in remain

several are plans more hope to health and mentioned, As with announcements other we we have months to engaged this like the in many come.

recently opportunity Of it adults million X, million we coverage Medicaid significant. be FUROSCIX market In those, be are effectively from In The reiterating. believe heart FUROSCIX the effective of is can suffering addressed by addition, is we July X that We episodes in X.X resulting million annually. estimated national X.X failure there FUROSCIX. U.S. events failure to also obtain alone XXXX. we’ll for informed believe worth heart

episode, which we total a of FUROSCIX from XX.X a is $X XX. we heart potential prescription we doses U.S. market adults assume there nearly suffer early from to And of in GX is are $X,XXX million range failure the access other If we this alone, doses of again, if seeing a At of to the per countries. have X FUROSCIX, billion. this opportunity four the that per are include stage, wide is

the aggressive more patients As some treating and this interventions discretion at is require physician of others. the than

funded of short-term and point, million of investments turn early deeper our with our continue launch cash, cash Parsons, call providing with ample over plan. us dive on metrics. Steve? Finally, this I’ll to into March we execute for than our $XXX are At equivalents President commercial Steve to to Senior as of Vice well XX, the more Commercial, resources

Steve Parsons

Thank John. you,

it February John indicated, and only launch As XX. FUROSCIX commercial announced of about been X.X while has on months availability we since the

pleased to with three team. an the We expected on with our are with territory start reps XX additional offices, progress. of and They’re add patterns hospitals, I’ll FUROSCIX demand to initial XX. currently conducting at of join continue field for by We representatives May face-to-face end total more to update for doctor’s have ready sales our We heart as stand emerge. a failure clinics. commercial in-services

to healthcare with designed on effective and XX and for instructions use at ensure ensuring providers healthcare hospitals to providers per the XXX crucial in-services Democrats to territory XXX training approximately in-service. in-service office transition is FUROSCIX. prescribing completion the of focus Targeting training readiness. on each provide and provided FUROSCIX The

target hours of XX office April a clinics by reflects physicians that XXX done focused This to these As the John mentioned, have relationships at and two and of the XX. top key March are clinic. sales as our through one as desire training total lasting throughout and with force force sales building is efficiently in-services these to are team XXX offices an completed interest clinics in-services This conducted in-services educational effectively. entire consultative or in doctor’s Many as the They providers. FUROSCIX of approach. specialized strong constituencies on and can healthcare

field FUROSCIX. results patient And by clinic XXX had still XXX it’s the ready with prescriptions to in total we early day early, March prescribers the be are needed encouraging filled we through to the maximize and total add of XXX of written the as reps a XX, while and access The more last will to prescriptions quarter.

have As prescriptions in to progress pending. balance of payers. March still The are or prescriptions either that XXX queued still due prescriptions written vast XX, prescriptions had for and patients the we doctors pending of majority are ready with of

We day. pending prescriptions each filled the bucket continue to into move with

have There varied, the was are a small also for patient number number too being small unreachable, prescriptions reason a little cancellations have or the patient’s abandoned high. hospitalized deceased. We and ranging from been copay a where of these

difference prescriptions written April, will As plan on we’ve far so and between expenses. for seen health placed out pocket the access patients we FUROSCIX formularies, filled narrow and more is already anticipate as patients lowering expanding of in would that

number the we doses to is of than prescription per believe prescription doses average continue right the higher long-term. moment, the to number but per At slightly four four, be

the last provider. functioning indicated Cardinal thus Health distribution, partnership with distribution strategic our third-party are far quarter, through as our of logistics pleased of terms In as our we we with process

is initial main specialty the our in reflected inventory specialty including first has revenue. working our which our with is Cardinal Cardinal three well pharmacy pharmacies, partners, shipped BioMatrix. to quarter specialty pharmacy,

specialty we As Cardinal recognize a revenue when moves from to pharmacies. reminder, FUROSCIX the

hub, for physicians patient out-of-pocket insurance reimbursement coverage benefits costs. our provides support Direct, and investigations determine FUROSCIX to

to patients the about to questions FUROSCIX. partners Our day provide are answer hours device specialty available use a XX pharmacy training of and

to other progress of drive adoption, This we and provider lot print of From engaged a conference a still although the the Overall, critical are electronic different some a have and and campaign and awareness, pleased but websites with and in of marketing and awareness activities, early multichannel key KOL many we tasks. the encompasses our engagement to development, on. work appearances, among collateral, perspective, development ongoing program commitment. market we are do, broad patient that we include are activities brand trajectory both

would CFO, concludes turn Nokes, Rachael to for Rachael? That my our like to now the over a call update. I financial update.

Rachael Nokes

product cost Steve. for One during $X.X Thank We October that generated million, the to a revenue cost of profit of and of expensed in $X.X of net of revenue FDA was inventory excludes approval the you, QX, million. XXXX $X.X XXXX. million first note quick revenue was the of gross prior yielding quarter

for development for and costs. XXXX. costs $X.X related Research million affairs and to device and costs, development a in study the was primarily expenses XXXX due decrease compared clinical to of employee in first regulatory million pharmaceutical costs, and $X.X the period decrease comparable quarter were quality and medical The

an The XXXX. were administrative million of expenses the and to $X.X for increase for for first selling, to March compared was million employee the professional and a net in reported a general XXXX increase in We $X.X expenses ending first XXXX. general of net due the the quarter and the of first compared XX, related service Selling, $XX.X administrative costs, XXXX for quarter period for quarter and primarily million in of to million of costs, quarter commercial XXXX loss loss costs. comparable $XX.X legal

As to of compared investments cash, as $XXX.X we in XX, term December equivalents XXXX, million held XX, cash of $XXX.X March million XXXX. and short

As scPharmaceuticals’ concludes was shares update. That the XX,XXX,XXX XX, of John? March outstanding XXXX, shares. total financial

John Tucker

At Thanks, for call our point, this the questions. remarks. Rachael. open This prepared concludes we’ll

Operator

sir. you, Thank

We session. Santangelo Instructions] The have will question-and-answer Glen now is first from ahead. from be question [Operator we Please Jefferies. conducting go a

Glen Santangelo

off Glad question. through my taking to see for Thanks great launches start. the evening. good Yes,

the So know were you did that the on filled. that. want question’s XXX Steve, don’t scripts or were to I of I congrats particularly some for XXX but on follow-up KPIs you gave if versus around the this that written for John,

I think, a deceased, heard say unreachable of that’s I patient might related Steve, some I due think copay. around the suggested hospitalized that been or but or reimbursement have them things you to of like you being combination unfortunately

more. narrow color So little wondering that if And can Thanks. that of us was you you of any around helpful. expected think would a sort I could be just said I out flesh sort you to bit give you

John Tucker

Steve for Thanks John. answer I’ll is the this question. Glen, Hey, that. let Steve?

Steve Parsons

the multiple that fill it’s percentage the and contribute which Yes, to happens. at that factors timing

in When got on up payer As in patient process payer so to process it case there’s immediately. that’s something, they to have HCPs, until that We what doesn’t the I include the pending, need everything healthcare early. needs. needs the on them, down can sending in in it providers I alluded, future, It’s call the that some need patient. the as might They pre-approval. of of immediately. the the some it The the get providing said. and everything prescriber, can hub slow it so forget habit depends front, that prescriptions are quickly. need the the They the reach they prescription the don’t payer we It’s they that some for FUROSCIXin

plans that care, the for patients some for resolve, In some top we’re We actively address a help the urgency less high of FUROSCIX and We the to five this, using are case, addition which thing us There’s just have who standard that. too the one is health coming patient. adjudication. there. And good still case. in they patient there’s think could order plan online X June do really where copays of then resolves, working

Glen Santangelo

for Thanks that details. Thanks. Perfect.

Steve Parsons

answer question? your Does that

Glen Santangelo

wanted Maybe Thanks. ask Yes, here. it in-services follow-up to-date. more completed I about one to just the does. I can on

you you maybe XX. saying a of April expect year your middle by target know have to that’s and expense mean ramp through quoted your heard don’t reconcile of have about the now an reps, I trying to think that and I going in-services I versus we goal the you’d that’s of you’ll maybe the have in-services, And I think XX of sort that how may completed. to of audience bulk it’s can will quarter. be done be balance like once XXX from scripts perspective John, Thanks. trajectory the the sales when you over of the might and just you the mistaken, what somewhere the that’s think if second I I’m at thought but conference as said bulk still

John Tucker

Yes.

So Glen, is John. this

of come places, the a with have want see the and booked in-service isn’t enough. territories moving satellite some number So to might one It’s in new existing territories. might complete, we forward, to important to still staff. XXX that, different locations. all their They both They kinds some us note part have of back in

But – the have be it a them or doing be this little bit, we be month to call so. into of still think by them we’ll bulk least I the average But the your to So done we at big third. I of quarter, here because services them be probably will think forever can of doing now, end this we but quarter. doing in in-services we’ll down want I think the be through bulk done next done, the of in want bulk just end don’t slows

Glen Santangelo

Thanks the for Okay. comments.

John Tucker

Thanks, Glen.

Operator

have from Securities. is Ruiz Roanna SVB next we go Please The question from ahead.

Roanna Ruiz

range Hey, me. on afternoon everyone, so progress and to congrats wanted the about for I far. from the A FUROSCIX. ask seen doses of few

I think to you mentioned X XX.

doses curious high which to – where of was those are what more I end So saying physicians that basically range what’s driving for basically? justify physicians patients the

John Tucker

you to? want do Steve, Yes.

Steve Parsons

around XX versus we going early Yes. any And quite of four we than just will toe their on, a little really end doses how the you’ll yet. not guidance – where to in drawing conclusions admit we this always what lot, putting hear It’s the the sure be it’s is those now, really someone moderate will to, think up. X,the it’s pool.They’re on higher we our right a work that two still

an are don’t they to, a day to fluid. – awful so they’re close they They need two severe they’ll address And an – The just who they people want use to and they really intervention. of hospital going get patients, want they’ll it to a ER, sometimes couple fluid. order to XX These to more pretty but close to that have try are then the want don’t is who lot it’s see, people more. try if the to and

those are the So extremes.

or on four. it’ll just big how to but think get, around they small moderate we we you give color wanted think I

Roanna Ruiz

are about would if FUROSCIX Okay, any you’re the great. prescriptions know curious some there. interesting. and around them if was pre-admission any And you super thinking seeing written, the versus to trying that detail early, but total just pretty give us understand I post-discharge themes I if dynamics it’s be could of

John Tucker

why a ahead? had go but you comment, I don’t Steve,

Steve Parsons

feel Yes. RXs our There’s are is more post-discharge, information setting fluid post-discharge patients who really happening that anecdotally. early in a more in are XX-day hub at this like pre-admission pre-admission with We a forms are RX star in We data lot anywhere than which capture stage. our don’t issues there the just or than period.

early makes the get sense. anecdotally, split, before hospitalized. it’s on So – say And the front it’s would launch. again, end in that don’t We they know but it’s I got more the

John Tucker

the hear way, for pre-admissions call. why might a is average seeing the reason what And John. joining anecdotally be the this by And I I these we’re we little think part Roanna, also of higher on thanks that Because being of has is days. number was discharged diuresis you think been about discharged if per the actively after for diuresis discharge back and has coming four in that’s think units patient days I it, five script. IV a five – or think,

think would would you So less. they need

script or more anecdotally per follow now. think I also So we’re doses right higher the what script it’s might of pre-admission kind the that hearing higher count

Roanna Ruiz

for I you Interesting. Super regional you’re sort last seeing like helpful. Any me, And what trends? of far? so fast growing noticing the curious, areas one are in was that

John Tucker

want Steve, to? do you

Steve Parsons

way. couldn’t think it’s I I don’t it’s that regional. say,

it’s and except reps region the cover have of others, not territories nation We XX are rep the have with ahead not we driven average, ahead in even regional, it’s big of for territories it’s country, the are of And where rep doing really center. people – the of that every the that. better norm. ahead the we But just

just So performances. I individual don’t rep have observations, regional

you a one I though. think John, early. little observation So it’s had

John Mohr

are had experience. have the doctors participated you as have I –that both we HOME – and in that about that that FREEDOM think AT a had that well doses we study and the – the it’s number had think – of asked have Roanna, I had

with experience, little have are they a so probably bit bit some are the more doses. of higher little comfort ones the and a that And have you more using

that impact So an well. had that as on has

John Tucker

But I been I and doctors seen early those it early, well writers And seen, think did FREEDOM Yes. thing, the have we into think of we’ve HOME early. can of gets they’ve and had that in which, writing participate the which embrace on study really the it the market. that but doctors have the and some they as is encouraging other is experience product, did hopefully, AT it’s

Roanna Ruiz

helpful. Great. Thanks. Got Super it.

John Tucker

Thanks, Roanna.

Operator

[Operator Instructions] Please have from Stacy from ahead. The next question we Ku go Cowen. TD is

Stacy Ku

questions much taking progress. our the and congratulations so for Thanks on

So different first, where it as lot we pre-admissions. seems think about seeing patients, of and the a centers to you’re be

So are not diuretics? a maybe any feedback So you’re So you have which easy to centers get you some low as able hanging first sense IV access of onboarding? heart more of for that’s the question. Are to fruit. kind failure getting might

their practices the post want just you doses? feedback would then providing more just And they to they’re would And be comfortable that single is What range of the see it you. ends? need kind really to use able hospital this this be do also admission? can of last, about second stays? clarify, a to Would adjusted be is helpful. Any clinicians. to then FUROSCIX What using Thank be need from they to shorten to for copay

John Tucker

all your I think, are those stage.

Steve Parsons

yes. Yes,

John Tucker

Steve show today.

Steve Parsons

around that rate? does. first affect So does places that think And any differentiation places between don’t? I have access the to adoption one that IV is it diuretics think I versus the

does. get right? it that think Did I I question

Stacy Ku

that doses. – kind why seeing any of kind of absolutely. high Are this that maybe of don’t range you have diuretics Yes. and Yes, IV centers really seeing you’re that’s

Steve Parsons

finish have true. job greater a access doses be them and many need them with have and And might normally in they places. days to done I day Yes. less, maybe at if IV, and other then they the if certainly diuresis they they’ve If much it’s Well, IV adopters days think one don’t do probably four don’t home could for a some the office treat the right. or office, for they FUROSCIX need they There’s access five unmet them sure. as than quicker need they’re in

rational. So that’s I think

setting discharge an I You think comfort in the asked that’s don’t it, about issue.

it using I think there’s that there. people happening comfortable don’t to want none there. say We are

to it I is pre-admission. the me think in little is people ask the and what characterize mix higher a

patients been next many the overloaded get days. XX in are just discharged to not There’s fluid who they’ve trouble There’s hospital. XX% the after as about in XX% who from

our you there’s patients And are numbers, think “pre-admission”. look the who raw patients. just But so I be those will more at

John Tucker

it’s stay. same journey. Stacy, we the the about patient, reduction it’s think cases, doc. key do It’s comfortable anecdotally their post-discharge, are think of hearing more physicians of John. think thing I more once It’s on the are pre-admission, is same we advertised, And we’re use which – patients using it, kind in even different one they kind of But I well in FUROSCIX, where doing think of treating the length and is get it’s and as that here. thing, a working

keep using appropriate doctors it, the more Once important. We why for from that discharge are if expand in and why that’s important. are to if they use in-services bouncing start even they’d and patients, we that the that comfortable usage think more That’s hospital. back positive pre-admission their patient then for is think potential with just that then early

think the did something I have to other I think, you add? John, question,

John Mohr

it’s point things – not Mohr used. sense be out just have give around that sense it I on there’s – to it’s to because the that commonly important think It’s I IV clinics, these they just ability IV very diuretics. makes Stacy, while make very, to to you should think common John only, the

And availability that to of we’ve it’s outpatient institutions because logistically be to diuretics the challenging the setting in about estimated do IV just sort able that that. have – administer of it’s XX% to

ability to it of the and have in IV sense that side. setting the on comfort have On give early side, to – be the flip of adopters kind that it demonstrated them some makes FUROSCIX those and do diuretics with for

John Tucker

for is seen a And the the X XX, the what we’ve is or your on third co-pays, question, that dose if co-pay it single it’s patient. Stacy, matter doesn’t

Stacy Ku

all for helpful. details. the incredibly you Okay. Thank That’s

John Tucker

Thanks, Stacy.

Operator

from ahead. Wainwright. Tsao question go from is Douglas next have Please The H.C. we

Douglas Tsao

how is they in-service for thanks of or in Maybe actually John, to write needing questions. quick participating call follow-up a from terms from physician rep. of my to in are sort an are taking are taking just it to start way different to of a Hi, they the HOME then physicians that and using And other the in than for a AT product who writing FUROSCIX? the Thank a people sales you. FREEDOM participated terms studies, in in starting

John Tucker

John. Hey, Thanks the Doug, question. it’s for

I’ll So have Steve in. probably chime and John

depends it in-service. think I the on

I and think or on think mind we clearly, in did – on, outreached but see asked to call doctors they we a talked some, some about were so last that at patient in-service, of the us and kind early already conference them, they doctors had the their either or did in-service I the phone. not a queue we all over for patients a of not, have they

maybe thing. bit on But and it’s the take the that’s as little longer a Again, them, the a scripts getting activate to so It’s that them, take And difference the after get number And call of maybe call. as the calls. and a which of an same do other one it soon and long-term had patient. to after in-service. we another some in-service. they behavior in It’s an between quick they want very and then you Other change to then were is the does is physicians, right the queue, just in-service a What a script, docs taken were writing going question, to it John? patient depends activated it.

John Mohr

study participate using don’t the FUROSCIX differently Mohr. than that And individuals I other that’s that the John Are true. in clinicians. think Doug,

and the they were And and they – the used they’re I evaluated the think – were criteria very were exclusion oriented. say criteria study and clinic way real I that controlled, very, in on It’s pragmatic the inclusion criteria very world. was very that today. they for would it while clinically were

same So using say they’re it as that the others. would way in probably I

that using was is those some say they what the doses just that very, were be think which that and it was more the of number a it that enrolling doses of bit little would they different. of patients study types similar. think of studies, way very, I they’re the the I in total very in comment But were a I using it, because in even

Steve Parsons

have they Yes, confidence.

elderly Some about helpful talk they for doing of higher them what patients? you BMI to to So their What us, there’s with. What olds about about practitioners programs questions for restrictions they’re XX-year I’ve physicians, to are them speaker BMI use speak it in and we’re my about, Because peer these to nurse it’s very all their no right? and patients patients? peer-to-peer who have lower patients and on speakers peer it used well, PAs. in can able and mind of

So a off that prescriber broad takes the reluctance the new to they unknown about potential the reservation, use. it’s because when a table hear

speaker do continue and to peer-to-peer, to we’ll So programs starting virtual, face-to-face. we’re ramp up

Douglas Tsao

Thank Great. you.

John Tucker

Thanks, Doug.

Operator

Group. [Operator ahead. Instructions] The next Please Maxim from question we have is Rahman from go Nazibur

Nazibur Rahman

on the for and initial my taking launch questions metrics. congrats thanks everyone, Hi

a few. Just

first do I have like is guess color that some could like approved, auth pass? question in I us prior are the you you to first rate of The provide prior regards the auth, – on, on

initial is and covers? bulk question purchase us And FUROSCIX, plan, five based many the you that my that color feedback you orders decision lives gone give and how My practices? set second question seen practices health I guess potentially some many and adds? from on top the plan that groups lives by to and on FUROSCIX of requests any is perception hospitals by have have physician cover How former the could on third national cover

John Tucker

last then over turn first one. Steve it let take to the it to So the for to maybe try me

quick will and there’s but purchases that pretty have, in purchases So just ballpark in offices pharmacies, might there have not have Part they its an from buy have to sure It’s they have the future make and the a patients that bill, by I the probably direct not would sense. outpatient they doesn’t B, access. systems make think might hospital infusion clinics, pharmacy be might

So think the to I write question? that’s was see. – What I that’s it… what second tried we

Nazibur Rahman

in brands? How five lives top this many

John Tucker

it who the we’d problem has, with tell – you So to it is. we love – that what

Steve Parsons

X, we June tell can you.

John Tucker

the commercial can It’s it June had – now, it’s happy I we’ve now there. well, negotiations – maybe at as really know you. them Part leave the D X, you’ll we’re But their we We’ve with on negotiations tell name well. plan.

So – It’s use we not but over… we’ll – name. their to allowed really

Steve Parsons

XX million.

John Tucker

of the big one covered guys. lives of the on million side business, XX it’s the so commercial

Steve Parsons

And think then PA. one the last was the I

John Tucker

Yes.

Steve Parsons

takes… long how Timing, that

Nazibur Rahman

What’s required?

Steve Parsons

that? What’s

Nazibur Rahman

What’s required the PA? on

Steve Parsons

What’s required in the PA.

Nazibur Rahman

those first of – pass? of how the Like many percentage those go through PAs what like

Steve Parsons

required better the around they’re getting Good It’s pass, that know if at be first data precisely. that I that’s should not than question. XX%, XX%. doctor mean, don’t I and actually sends more information XX%, the in

John Tucker

Now, that XX%, still keep could prior in be high co-pay. a that though the XX%, auth have very still mind they – could They approved. could just

obviously patient So a has so. but PA the obstacle, is getting percent a approved coinsurance, still that’s an if then huge,

Steve Parsons

think Class Well, that or patient have the Yes. that we’ve so not I in has Class indicated be III, to for moment. come some IVs at through said II the Class

bit little quickly done, got that, they so. a Medicare they factor of to how be through has the have there’s right they So and If in. about go information, rules provide the

Nazibur Rahman

my Got it. on and and Thanks answering questions the congrats for taking initial launch.

John Tucker

Naz. you, Thanks. Thank

Operator

turn the closing at this no like go sir. time. There I to floor ahead, for questions back over are comments. John to further Please Tucker would

John Tucker

of that Okay. patients That commercial affordable in look information growth We take this good will to this and nice afternoon. for we we again heart evening. you continued during forward with We which August. We to revenue. you execute the more call a in trajectory prescriptions a both call quarter providing anticipate update as to away access our to are continue second pleased failure progress Thank plan. with into translate percentage from believe and have in our hope our concludes on our we date FUROSCIX,

Operator

us. sir. you, then today’s and you Thank Thank conference. joining that Ladies for concludes gentlemen,

now You may disconnect your lines.

scPharmaceuticals (SCPH) 10 May 232023 Q1 Earnings call transcript